User profiles for M. Mazighi
 | mikael mazighiuniversity of paris Verified email at aphp.fr Cited by 18056 |
Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review
…, L Cabrejo, C Guidoux, I Klein, P Amarenco, M Mazighi - Stroke, 2013 - Am Heart Assoc
Background and Purpose— The potential detrimental effect of diabetes mellitus and
admission glucose level (AGL) on outcomes after stroke thrombolysis is unclear. We evaluated …
admission glucose level (AGL) on outcomes after stroke thrombolysis is unclear. We evaluated …
[HTML][HTML] Endovascular therapy after intravenous t-PA versus t-PA alone for stroke
Background Endovascular therapy is increasingly used after the administration of intravenous
tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic …
tissue plasminogen activator (t-PA) for patients with moderate-to-severe acute ischemic …
Large vessel occlusion stroke due to intracranial atherosclerotic disease: identification, medical and interventional treatment, and outcomes
…, M Anadani, E Almallouhi, R Chatterjee, M Mazighi… - Stroke, 2023 - Am Heart Assoc
Large vessel occlusion stroke due to underlying intracranial atherosclerotic disease (ICAD-LVO)
is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk …
is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk …
Mothership versus drip and ship for thrombectomy in patients who had an acute stroke: a systematic review and meta-analysis
Background The effectiveness of mechanical thrombectomy (MT) in acute ischemic stroke
due to large vessel occlusion is time-dependent. While only stroke centers with endovascular …
due to large vessel occlusion is time-dependent. While only stroke centers with endovascular …
[HTML][HTML] Endovascular therapy for stroke due to basilar-artery occlusion
Background The effectiveness of endovascular therapy in patients with stroke caused by
basilar-artery occlusion has not been well studied. Methods We randomly assigned patients …
basilar-artery occlusion has not been well studied. Methods We randomly assigned patients …
A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects
…, L Cabrejo, JM Olivot, O Simon, M Mazighi… - The Lancet …, 2007 - thelancet.com
Background Diagnosis and treatment of cerebral and retinal transient ischaemic attacks (TIAs)
are often delayed by the lack of immediate access to a dedicated TIA clinic. We evaluated …
are often delayed by the lack of immediate access to a dedicated TIA clinic. We evaluated …
European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute …
Background Mechanical thrombectomy (MT) has become the cornerstone of acute ischemic
stroke management in patients with large vessel occlusion (LVO). Objective To assist …
stroke management in patients with large vessel occlusion (LVO). Objective To assist …
Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER …
… Dr Mazighi reports consulting for Servier and Acticor, funding for teaching from Amgen and
Pfizer, and travel reimbursements from Boehringer Ingelheim, Zeneca, and Bayer. Dr Piotin …
Pfizer, and travel reimbursements from Boehringer Ingelheim, Zeneca, and Bayer. Dr Piotin …
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial
Background Whether thrombectomy alone is equally as effective as intravenous alteplase
plus thrombectomy remains controversial. We aimed to determine whether thrombectomy …
plus thrombectomy remains controversial. We aimed to determine whether thrombectomy …
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 …
Background The IMS III trial did not show a clinical benefit of endovascular treatment
compared with intravenous alteplase (recombinant tissue plasminogen activator) alone for …
compared with intravenous alteplase (recombinant tissue plasminogen activator) alone for …